While these results indicate increased importance of CD8+ T cells in SARS-CoV-2, in SARS-CoV-1, 100% of patients had reduced CD4+ T cells, and 87% experienced a decrease in CD8+ T cells, with 85% experiencing lymphopenia [45]. This evidence concerns the gene CD8A and lymphopenia.